Skip to main content
SpringerLink
Log in

Consider the special circumstances of the individual when using insulin therapy in older diabetics

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Mooradian AD. Special considerations with insulin therapy in older adults with diabetes mellitus. Drugs Aging 2011; 28(6): 429–38

    Article  PubMed  CAS  Google Scholar 

  2. Saudek CD, Hill Golden S. Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus. Drugs Aging 1999; 14(5): 375–85

    Article  PubMed  CAS  Google Scholar 

  3. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. No. 62. London: BMJ Publishing Group Ltd and RPS Publishing, 2011 Sep

    Google Scholar 

  4. Bott U, Ebrahim S, Hirschberger S, et al. Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetic Med 2003; 20(8): 626–34

    Article  PubMed  CAS  Google Scholar 

  5. Dunn CJ, Plosker GL. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus. Pharmacoeconomics 2002; 20(14): 989–1025

    Article  PubMed  CAS  Google Scholar 

  6. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Systematic Rev 2004; (2): CD003287

    Google Scholar 

  7. Durso SC. Using clinical guidelines for older adult patients with diabetes mellitus and complex health status. JAMA 2006; 295(16): 1935–40

    Article  PubMed  CAS  Google Scholar 

  8. American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care 2010; 33Suppl. 1: S62–9

    Article  Google Scholar 

  9. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28(7): 1568–73

    Article  PubMed  CAS  Google Scholar 

  10. Heise T, Weyer C, Serwas A, et al. Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 1998; 21(5): 800–3

    Article  PubMed  CAS  Google Scholar 

  11. Symlin® (pramlintide acetate) injection: US prescribing information. San Diego (CA): Amylin Pharmaceuticals, Inc., 2008 Jul

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Consider the special circumstances of the individual when using insulin therapy in older diabetics. Drugs Ther Perspect 28, 15–17 (2012). https://doi.org/10.2165/11606190-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11606190-000000000-00000

Search

Navigation